Barbara Leyman serves as Executive at SUTRO BIOPHARMA, INC., where they oversee executive responsibilities. Since joining the company, Barbara Leyman has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 8, 2025 involved selling 8,944 shares valued at $7.0K.
Barbara Leyman currently holds 16,056 shares of SUTRO BIOPHARMA, INC. (STRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Leyman has been a net neutral trader of STRO stock. They have purchased $0 and sold $0 worth of shares.
Barbara Leyman's most recent insider trade was on Jul 8, 2025, when they sold 8,944 shares at $0.78 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |